New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Federal agency opposes J&J’s new 340B discount model, promises to take ‘actions as warranted’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 27, 2024

Telehealth providers can drive antibiotic overuse — or choose to combat it

Ho Anh had just started working at Lemonaid Health when he was caught up in a sting. In 2017, after receiving reports about the telehealth

April 11, 2024

The Benefits of a Stand-Alone Care-Management Program

Mary Bacaj, Ph.D., President of Value-Based Care at Conifer Health Solutions Poorly managed chronic conditions—most of which are related to lifestyle—cost employers $36.4 billion each

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.